Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Marketplace Revolution

Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Engagement Manager, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Principal, Health & Life Sciences, Oliver Wyman

How pharmaceutical companies can better define, measure, and deliver value to patients.

Principal, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.

Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?

Partner, Health & Life Sciences, Oliver Wyman

Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.

Principal, Oliver Wyman Actuarial Consulting
Global Head, Health Services, Oliver Wyman
Principal, Oliver Wyman

A discussion on how mega mergers affect consumers and how consolidation is driving the new future of healthcare.

2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe